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Abstract
Background: A febrile seizure (FS) is the most common convulsive disorder in children. Activation of cytokine
network is involved in FS pathogenesis. Adiponectin, leptin and IL-6 are the major adipocytokines secreted by fat
cells. To date, only a few studies concerned the association of adipocytokines with febrile seizures. In this study, we
tried to investigate serum and CSF levels of adiponectin, leptin, and interleukin-6 (IL-6); as adipocytokines, for the
first time in Egyptian children with febrile seizures.
Methods: This was a prospective cross-sectional study included one hundred patients with febrile seizure, and
matched with age, gender, 100 children with febrile illness without seizures (febrile control, FC) and 100 healthy
control group (HC). Serum and cerebrospinal fluid (CSF) levels of adiponectin, leptin, and (IL-6) were measured by
enzyme-linked immunosorbent assay (ELISA) method.
Results: Serum adiponectin was significantly higher in children with FS (16.8 ± 3.7 ug/ml) and the FC group (18.3 ±
4.3 ug/ml) compared to the HC group (9.5 ± 2.2 ug/ml); P < 0.05, respectively. Serum leptin was significantly lower in
children with FS (0.9 ± 0.3 ng/ml) compared to both the FC group (4.7 ± 1.2 ng/ml) and the HC group (1.8 ± 0.4 ng/
ml); P < 0.01, respectively. Children with FS had significantly higher serum IL-6 levels (43.7 ± 11.7 ng/ml) than the FC
group (21.9 ± 4.5 ng/ml) and the HC group (6.5 ± 1.8 ng/ml); P < 0.01, respectively. Patients with simple febrile
seizures (SFS) had serum and CSF adiponectin levels similar to those with complex febrile seizures (CFS); (P > 0.05).
Serum and CSF leptin levels were significantly lower in patients with CFS compared to the SFS group (P < 0.05).
Serum and CSF IL-6 levels were significantly higher in patients with CFS compared to the SFS group (P < 0.01). On
multivariate logistic regression analysis, the high serum IL-6 levels was the most significant risk factor associated
with febrile seizures among studied children (OR: 6.2; 95 % CI: 3.58 –10.57; P = 0.0001).
Conclusion: Our data brought a novel observation that some adipocytokines like leptin and IL-6 could be, at least
in part, an aetiopathogenetic factor in the manifestation of febrile seizures in susceptible Egyptian children.
Moreover, we observed a significant association between high CSF IL-6 levels and susceptibility to complex febrile
seizures as did the low CSF leptin levels.
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Background
Febrile seizures comprise common convulsive disorders
in children between 6 months and 6 years of age, ac-
counting for 30 % of all seizures in children [1]. Children
with a simple febrile seizure have potential for recur-
rence and 2–7 % of children may develop epilepsy by
adolescence [2]. Complex interaction between immune-
inflammatory process, cytokines activation, and genetic
factors is involved in febrile seizures pathogenesis [3].
The adipocytes are known to have an active endocrine
function; adiponectin, leptin, interleukin-6 (IL − 6), tumor
necrosis factor (TNF − α), vaspin, ometin and visfatin are
produced in adipose tissue. These hormonally active
peptides have common properties with cytokines, and
therefore referred to as adipocytokines [4]. Adiponectin
is a double-acting cytokine, which not only has anti-
inflammatory effects, but it has also proinflammatory
effects [5]. Adiponectin is protective against ischemic
brain injury by modulating inflammatory pathway and
endothelial functions and acts centrally to control per-
ipheral metabolism [6]. Interestingly, PPARγ agonists,
which are known to increase adiponectin expression,
protect against seizure-related pathology [7]. Leptin af-
fects energy homeostasis by decreasing food intake and
by acting on lipogenesis and fatty acid oxidation [8].
Leptin has roles similar to proinflammatory cytokines
[5]. Experimental work suggested that leptin might be
an endogenous modulator of neuronal excitability [9].
Leptin has been proposed for clinical use as an anticon-
vulsant in addition to its potential metabolic effects in
humans [10].
Pro-inflammatory and anti-inflammatory cytokines play
an important role in regulating the febrile response during
infection. Among these cytokines, interleukin-6 is the key
acute-phase cytokine [11]. The association of IL-6 gene
polymorphism and susceptibility to febrile seizures is still
controversial. Increased levels of IL-6 have been reported
in the plasma and cerebrospinal fluid of febrile seizure pa-
tients suggesting that IL-6 is activated during the acute
stage of a febrile seizure [12, 13].
To date only a few studies concerned the association
of adipocytokines with febrile seizures. In this study, we
tried to investigate serum and CSF levels of adiponectin,
leptin, and (IL-6); as adipocytokines, for the first time in
Egyptian children with febrile seizures.
Methods
This was a prospective cross-sectional study performed
in Zagazig University Children Hospital, and out-
patient clinics in the same hospital from May 2013 to
October 2015.
One hundred children; who had febrile seizures as di-
agnosed in the Department of Pediatrics in the same
hospital, were enrolled in this study. The age of the
patients ranged from 6 months to 6 years (mean,
31 months). Diagnosis of febrile seizures followed the
criteria established in the 1989 International Classifica-
tion of Epileptic Syndromes [14]. The electroencephalo-
gram (EEG) was normal for all patients or showed mild
nonspecific abnormalities.
Exclusion criteria
Patients with febrile seizures beginning at the age of
6 years or later, afebrile seizures, evidence of intracranial
infection, epileptiform EEG traits or metabolic imbal-
ance. Patients with diseases known to affect adipocyto-
kines such as diabetes, genetic syndromes, and obese
patients, were also excluded.
The mean age at the onset of febrile seizures was
18 months (range, 6–43months). Within the group with
complex febrile seizures, 21 patients had experienced
two or more seizures, five patients had experienced focal
seizures, and nine patients had experienced prolonged
seizures lasting longer than 20 min. Thirty-one patients
had a family history of febrile seizures, and 4 patients
had a family history of epilepsy.
Two hundred healthy children, of comparable age and
gender; without a history of febrile or afebrile seizures,
were enrolled as control groups. We subdivided our
controls into two groups.
FC group (n = 100): children hospitalized at our
pediatric department with fever due to infection except
for central nervous system infection;
HC group (n = 100): who attended pediatric outpatient
clinics for preoperative evaluation for elective surgery.
All patients and controls included were subjected to
proper history taking, thorough clinical and detailed
neurological examination. Laboratory investigations were
done for all studied children and included: complete
blood count (CBC) including blood indices, ESR and C-
reactive protein (CRP), serum electrolytes (Na, K, Ca
levels), blood glucose level, Urine culture and sensitivity
tests, Liver function and kidney function tests.
Venous blood samples were obtained from patients
within 30 min of the time of seizure, centrifuged and
stored at _20 _C till the time of use. Control samples
were collected and similarly analyzed. CSF samples were
obtained from all FS patients based on the clinical judg-
ment of the attending pediatrician. The CSF samples
had normal cell count <5 cells/μl and normal protein
levels (0.2–0.5 g/l).
Serum and CSF adiponectin and leptin measurement
Serum and CSF adiponectin was measured by ELISA
(AviBion, human adiponectin, Acrp30, Vantaa, Finland)
that has assay range: 0.2 mg/L→ 60 mg/L. Serum and
CSF Leptin was detected with commercially available
test kits were used to measure leptin (enzyme-linked
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immunosorbent assay [ELISA] method, DRG Inter-
national, Mountainside, NJ, USA), that has assay range
of 0.25 – 120 ng/mL.
Serum and CSF interleukin 6 (IL6) measurements
The concentrations of IL6 in serum and CSF were esti-
mated using a double antibody sandwich ELISA (kit pro-
vided by Biosource EuropeS.A., Belgium) according to
the manufacturer’s instructions by using standard curve.
Statistical analysis
SPSS (version 22.0. Armonk, NY, USA: IBM Corp. 2013)
was used for data analysis. The data are expressed as the
mean ± SD or median (min-max) where appropriate.
Test selection was based on evaluating the variables for
normal distribution using the Shapiro-Wilk test. Chi-
square test, Student t test and ANOVA test were used.
Multiple comparison analysis by the least significant
difference (LSD) was used. This test detects statistical
difference between two means when ANOVA test refers
to significances. Binomial logistic regression analysis
was used to define the association between febrile sei-
zures (as the dependent variable), estimated plasma adi-
pocytokines levels and clinical parameters (as the
independent variables). P value < 0.05 is considered to
be statistically significant.
Ethics
Informed parental consent was obtained to be eligible
for enrollment into the study. The study was done
according to the rules of the Local Ethics Committee of
Faculty of Medicine, Zagazig University, Egypt. The
study was approved by our local ethics committee of
University of Zagazig, Egypt, reference number ZU_IRB
#2597/–17–5–2013.
Results
Our study included 100 patients with FS (65 patients with
Simple FS and 35 patients with Complex FS, their age
ranged from 6 to 72 months (mean 31 months), 51 males
and 49 females) and 200 children as FC and HC groups
whose clinical and laboratory characteristics are listed in
Table 1. The control groups were age, gender and BMI
matched to children with FS. Compared to the FC group,
children with FS showed no significant differences in
terms of body temperature on admission, type of infection
(bacterial/viral), duration of fever before blood sample
(<24 h/>24 h), white blood cell (WBC) count and C-
reactive protein (CRP); all P > 0.05; (Table 1).
Serum adiponectin was significantly higher in children
with FS (16.8 ± 3.7 ug/ml) and the FC group (18.3 ± 4.3
ug/ml) compared to the HC group (9.5 ± 2.2 ug/ml); P <
0.05, respectively. However, no significant difference was
observed between FS and FC groups as regards serum adi-
ponectin; (P > 0.05), (Fig. 1). Serum leptin was significantly
lower in children with FS (0.9 ± 0.3 ng/ml) compared to
both the FC group (4.7 ± 1.2 ng/ml) and the HC group
(1.8 ± 0.4 ng/ml); P < 0.01, respectively. On the other hand,
serum leptin was significantly higher in the FC group
compared to the HC group; (P < 0.01), (Fig. 2).
Table 1 Baseline clinical and laboratory characteristics of FS patients and the control groups
FS group FC group HC group P
(n = 100) (n = 100) (n = 100)
Age (months) 31 ± 7.5 33 ± 6.9 29 ± 8.3 >0.05
Gender (Male/female)d 51/49 50/50 48/52 >0.05
BMI (kg/m2) 15.9 ± 1.2a 16.3 ± 1.6a 15.7 ± 1.8a >0.05
BT (C) on admission 38.9 ± 1.2 38.5 ± 1.3 _ >0.05
Type of infection d (bacterial/viral) 63/37 59/41 _ >0.05
Duration of fever d Before blood sample(<24 h/>24 h) 71/29 75/25 _ >0.05
Type of Febrile seizure : Simple/Complex 65/35 - -
WBC (× 109/L) 13.5 ± 4.3a 14.1 ± 5.6a 8.7 ± 2.6b <0.01
CRP (mg/dl) 38.4 ± 9.6a 41.0 ± 11.5a 3.8 ± 1.2b <0.01
Serum Adiponectin (ug/ml) 16.8 ± 3.7a 18.3 ± 4.3a 9.5 ± 2.2b <0.05
Serum Leptin (ng/ml) 0.9 ± 0.3a 4.7 ± 1.2b 1.8 ± 0.4c <0.01
Serum IL-6 (ng/ml) 43.7 ± 11.7a 21.9 ± 4.5b 6.5 ± 1.8c <0.01
Abbreviations: FS febrile seizures, FC febrile control, HC healthy control, BMI body mass index, BT body temperature, WBC white blood cell, CRP C-reactive protein,
IL-6 Interleukin 6
Values are mean ± standard deviations or median (minimum- maximum)
The P value is for ANOVA.
a, b and c on means refer to significant difference between means when ANOVA test refers to significances by multiple comparison analysis (aa, bb, cc = non-
significant, ab, ac, bc = significant).
dChi-square test
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Children with FS had significantly higher serum IL-6
levels (43.7 ± 11.7 ng/ml) than the FC group (21.9 ±
4.5 ng/ml) and the HC group (6.5 ± 1.8 ng/ml); P < 0.01,
respectively; (Fig. 3).
Patients with simple febrile seizures had serum and CSF
adiponectin levels similar to those with complex febrile
seizures (P > 0.05); Table 2. Of note, serum and CSF leptin
levels were significantly lower in patients with CFS com-
pared to the SFS group (0.6 ± 0.07 vs 3.7 ± 0.8 ng/ml for
serum leptin and 0.24 ± 0.08 vs 1.48 ± 0.3 ng/ml for CSF
leptin, respectively; P < 0.05) Table 2. On the other hand,
serum and CSF IL-6 levels were significantly higher in pa-
tients with CFS compared to the SFS group (55.8 ± 13.7vs
31.9 ± 7.6 ng/ml for serum IL-6 and 39.06 ± 5.7 vs 22.3 ±
6.8 ng/ml for CSF IL-6, respectively; P < 0.01) Table 2.
Meanwhile, no significant differences were observed be-
tween FS patients’ subgroups as regards age, gender, BMI,
body temperature on admission, duration of fever, WBC
count or CRP (all P > 0.05; Table 2).
In the univariate logistic regression analysis high
serum adiponectin, low serum leptin, and high serum
IL-6 levels were significantly associated with the risk of
febrile seizures among studied FS patients, but age, gen-
der, body temperature on admission, type of infection,
duration of fever, WBC count and CRP were not. When
multivariate logistic regression analysis was performed,
the high serum IL-6 levels was the most significant risk
Fig. 1 Serum adiponectin level among studied groups
Fig. 2 Serum leptin level among studied groups
Fig. 3 Serum IL-6 level among studied groups
Table 2 Comparison between patients with simple febrile






Age (months) 30 ± 6.5 33 ± 7.2 >0.05
Gender (Male/female)a 34/31 17/18 >0.05
BMI (kg/m2) 15.6 ± 3.2 16.5 ± 3.1 >0.05
BT (C) on admission 38.7 ± 1.2 39.3 ± 1 >0.05
Duration of fever Before blood
sample (<24 h/>24 h)
47/18 24/11 >0.05
WBC (× 109/L) 14.7 ± 6.1 13.5 ± 3.4 >0.05
CRP (mg/dl) 40.2 ± 6.9 36.7 ± 5.3 >0.05
Serum Adiponectin (ug/ml) 3.1 ± 1.1 2.9 ± 0.7 >0.05
Serum Leptin (ng/ml) 3.7 ± 0 0.6 ± 0.07 <0.05
Serum IL6 (ng/ml) 31.9 ± 7.6 55.8 ± 13.7 <0.01
CSF Adiponectin (ug/ml) 1.8 ± 1.2 1.6 ± 0.9 >0.05
CSF Leptin (ng/ml) 1.48 ± 0.3 0.24 ± 0.08 <0.05
CSF IL6 (ng/ml) 22.3 ± 6.8 39.06 ± 5.7 <0.01
Abbreviations: SFS Simple febrile seizures, CFS Complex febrile seizures, BMI
body mass index, BT body temperature, WBC white blood cell, CRP C-reactive
protein, IL-6 Interleukin 6, CSF cerebrospinal fluid
Values are mean ± standard deviations
P < 0.05 significant, (Student t test)
aChi-square test
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factor associated with febrile seizures among studied
children (OR: 6.2; 95 % CI: 3.58 –10.57; P = 0.0001), but
low serum leptin levels were also significantly associated
with febrile seizures (OR: 2.2; 95 % CI: 1.09 –4.78; P =
0.047); Table 3.
Discussion
Although febrile seizure is the most common form of
seizures in children [15], its exact pathophysiology re-
mains not fully understood. Several recent studies
highlighted the role of cytokine network activation in fe-
brile seizures etiopathogenesis [12, 13]. Recent experi-
mental work suggested that peripheral endocrine and
metabolic factors are capable of modulating seizure
threshold and seizure-related pathology by acting on
CNS neurons to trigger intracellular signaling pathways
or modulating neuronal activity [7, 16]. This idea has
raised a great deal of our interest in the role of the adi-
pocytokines in the pathogenesis of febrile seizures. Adi-
ponectin, leptin and IL-6 are the major adipocytokines
secreted by fat cells [17].
Adiponectin is specifically expressed in human adipo-
cytes. Adiponectin has multiple functions not only in
the peripheral tissues, but also in the central nervous
system. Adiponectin exerts its biological effects via its
two receptors, and AdipoRs receptors, AdipoR1 and
AdipoR2, are widely expressed in the central nervous
system [18]. Central adiponectin has potent electro-
physiological effects; raising the possibility that adipo-
nectin directly modifies seizure activity and brain
pathology [19]. In our study, we observed that serum
adiponectin was significantly higher in children with FS
and the FC group compared to the HC group. However,
we couldn’t find any difference between FS and FC
groups or between SFS and CFS patients in terms of
serum adiponectin. Furthermore, patients with simple
febrile seizures had CSF adiponectin levels similar to
those with complex febrile seizures.
Similar to our results, a recent study by Güven et al.
[20] who evaluated serum adiponectin levels in Turkish
children with febrile seizures. This research suggested
that elevated levels of serum adiponectin was an acute
phase reactants in FS and FC groups that did not con-
tribute to the development of FS.
Experimental work confirmed that adiponectin en-
hances tolerance against brain ischemia through anti-
inflammatory and anti-oxidative mechanisms. Lee et al.
[21] reported that adiponectin deficiency resulted in an
increase in body fat, impaired glucose tolerance and in-
creased lipids, and these changes were associated with
increased seizure severity and hippocampal pathology.
Previous studies suggested the neuroprotective action of
adiponectin via an endothelial nitric oxide synthase-
dependent mechanism [22]; meanwhile Chen et al. [6]
confirmed the anti-inflammatory action of adiponectin
against cerebral ischemia-reperfusion injury. However,
little is known about the cerebroprotective action of adi-
ponectin as well as its molecular mechanisms.
In the present study, children with FS had significantly
lower serum leptin levels in comparison to both the FC
group and the HC group; by contrast, febrile control
children had significantly elevated serum leptin levels,
compared to children with FS and healthy controls.
Interestingly, serum leptin levels were significantly lower
in patients with CFS compared to those with SFS. Our
multivariate regression analysis model indicated that low
serum leptin level was an independent risk factor associ-
ated with febrile seizures among studied children. In an
attempt to explain our results concerning the anticon-
vulsant action of leptin, we studied the CSF level of lep-
tin in our patients, which was significantly lower in
patients with CFS compared to those with SFS. This
finding has never been reported in children with FS.
Our results were different from those of Khoshdel et al.
[23] who reported no important change in serum leptin
levels between children with simple febrile seizures and
febrile children without seizures.
Leptin, a 16 kDa neurohormone predominantly syn-
thesized and released into blood by adipocytes and
serves as a signal for the brain of the body’s energy store
[8]. Leptin controls food intake through its receptors in
the hypothalamus by inhibiting the release of NPY, so
leptin is a key hormone in the regulation of body weight
and nutrition [8]. Recent experimental work confirmed
leptin’s anticonvulsant action in seizure models. Xu et al.
[10] reported that intranasal administration of leptin
produced elevated brain and serum leptin levels and de-
layed the onset of pentylenetetrazole-induced general-
ized convulsive seizures. Leptin was found to inhibit
ionotropic α-amino-3-hydroxy-5-methyl-4-isoxazole pro-
prionic acid (AMPA) glutamate receptor–mediated synap-
tic transmission in hippocampal brain slices. This
suppression of glutamate transmission by leptin can di-
minish the likelihood of seizure generation and propaga-
tion [10]. These findings, together with our results,
support the hypothesis that the high serum leptin levels
observed in FC group could be protective against febrile
seizures, whereas lower serum leptin levels were
Table 3 Multiple logistic regression analysis of serum
adipocytokines levels as risk factors for febrile seizures among
studied subjects
Risk Factor Coefficient P Value Odds Ratio 95 % CIa
Serum Adiponectin
(ug/ml)
0.031 0.174 1.031 0.987- 1.078
Serum Leptin (ng/ml) 0.778 - 0.047 2.2 1.09 –4.78
Serum IL6 (ng/ml) 1.8171 0.0001 6.2 3.58 –10.57
aCI indicates confidence interval
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associated with FS in susceptible children. The future may
hold a greater promise for therapeutic success in using
metabolic hormones and their signaling modalities to
combat seizures disorders rather than obesity.
IL-6 is a pleiotropic proinflammatory cytokine with a
wide range of biological activities in immune regula-
tion, hematopoiesis, inflammation, and neoplasia and
interleukin-6 demonstrates a strong correlation with
fever [24]. A dual role of IL-6 in seizures has been dem-
onstrated in FS experimental models [25–27]. An earl-
ier study by Biber et al. [25] confirmed that stimulation
of astrocytes and brain slices of cortex with IL-6 in-
duced adenosine A1 receptor mRNA which is a power-
ful endogenous anti-convulsive substance. Fakuda et al.
[26] reported that interleukin-6 plays an anti-
convulsive role in experimental hyperthermia-induced
seizures which might suggest similar properties of this
cytokine in children with febrile seizures. On the other
hand, intranasal administration of IL-6 exacerbated the
severity of seizures induced by pentylenetetrazole on
models of FS, supporting a pro-convulsant effect [27].
Our data revealed that children with FS had signifi-
cantly higher serum IL-6 levels compared to both the
FC group and the HC group. In addition, serum and
CSF IL-6 levels were significantly higher in patients with
CFS compared to the SFS group.
Our multivariate logistic regression model indicated
that the high serum IL-6 level was the most significant
risk factor associated with febrile seizures among stud-
ied children.
These results are concordant with those of Virta et al.
[13] who found that plasma interleukin-6 levels and
interleukin-1 receptor antagonist (IL-1 RA) were signifi-
cantly higher in 55 patients with febrile seizures, com-
pared with 20 age-matched, febrile control subjects. The
authors recorded that elevated levels of IL-6, IL-1 RA
and IL-10 were also found in the CSF of patients with
FS, but CSF IL-6 levels were detectable in all studied pa-
tients with FS. Straussberg et al. reported an increase in
the production of IL-1b, IL-6, and IL-10 cytokines by
lipopolysaccharide-stimulated mononuclear cells from
individuals of 13 children with history of febrile seizures
and 11 controls, but the secretion of IL-6 and IL-10 in
response to lipopolysaccharide was higher in those with
a previous history of convulsions [28]. Hu et al. per-
formed a study on 9 children with febrile seizures and
21 patients with severe acute encephalitis. In multivari-
ate analysis, plasma IL-6 was significantly increased in
patients with FS compared to those with severe acute
encephalitis, suggesting that IL-6 is activated during the
acute stage of a febrile seizure [12].
Our results confirm and extend these findings by dem-
onstrating that elevated serum and CSF IL-6 levels in FS
patients could be, at least in part, an aetiopathogenetic
factor in the manifestation of febrile seizures in susceptible
children. Lehtimäki et al. [29] explained that increased
brain proinflammatory cytokines decrease the threshold
for individual seizures; supporting the suggestion that
neuroinflammation may contribute to epileptogenesis in
the developing brain [29, 30]. However, final proof of a
causal role of elevated serum and CSF IL-6 levels in febrile
seizures pathogenesis is still lacking.
To the best of our knowledge, we demonstrated for
the first time the association between serum and CSF
levels of adiponectin, leptin, and (IL-6); as adipocyto-
kines, and febrile seizures in Egyptian children. However,
the small sample size was one of our limitations in this
study; we suggest that multicenter approaches may be
necessary to attain larger sample size. Interictal adipocy-
tokines levels were not measured in our patients with fe-
brile seizures which was another limitation in our study.
Conclusion
Our data brought a novel observation that some adipo-
cytokines like leptin and IL-6 could be, at least in part,
an aetiopathogenetic factor in the manifestation of fe-
brile seizures in susceptible Egyptian children. Moreover,
we observed a significant association between high CSF
IL-6 levels and susceptibility to complex febrile seizures
as did the low CSF leptin levels.
Future more extended studies on febrile seizures in-
vestigating the serum and CSF levels of those and other
adipocytokines; like TNF − α, vaspin, ometin and visfatin,
will provide an additional understanding of the possible
role of adipose tissue in the susceptibility to febrile seiz-
ure and progression to epilepsy.
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